Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 06-02-2024 |
Asset Class: |
Benchmark: BSE Healthcare TRI |
TER: 2.39% As on (30-12-2024) |
Status: Open Ended Schemes |
Minimum Investment: 100.0 |
Minimum Topup: 100.0 |
Total Assets: 283 Cr As on 31-12-2024(Source:AMFI) |
Turn over: - | Exit Load: Exit load of 1%, if redeemed within 1 months. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Small Cap
34.08%
Others
12.16%
Large Cap
23.41%
Mid Cap
30.35%
There are no scheme documents available